RSV Vaccination Shows Substantial Benefits for Older Adults
An adjuvanted RSV vaccine has the potential to significantly decrease the burden of RSV among adults aged 60 and older in the United States, according to results published in Infectious Diseases and Therapy. Desmond Curr ...